Antonio Boccia

Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke

Robert Paul, Zheng G. Zhang, Brian P. Eliceiri et al. · Nature Medicine · 2001 · 341 citations

Ischemic Stroke, Src Deficiency, Medicine +12

A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity

Jianying Dong, Arlene Sereno, Dikran Aivazian et al. · mAbs · 2011 · 78 citations · Full text

Tumor Biology, Single Mabs, Parental Monoclonal Antibodies +14

Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine—a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays

Glenn Noronha, Kathy Barrett, Antonio Boccia et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 46 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Chemistry +13

Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity

Jianying Dong, Arlene Sereno, William B. Snyder et al. · Journal of Biological Chemistry · 2010 · 38 citations · Full text